Curaleaf, one of the largest multistate cannabis operators based in New York – comprising a cannabis company that sells in different states in the United States – will enter the Toronto Stock Exchange (TSX) this Thursday, December 14 under the symbol CURA.
This strategic and financial move follows the conditional approval of the company’s listing on the Toronto Stock Exchange in order to access a greater number of investors on the Canadian stock exchange. The company’s leadership, including CEO Matt Darin and Executive Chairman Boris Jordan, will mark this milestone by ringing the TSX opening bell.
.@Boris_JordanExecutive Chairman, @Curaleaf_Inc (TSX:CURA), and his team joined us to open the market and celebrate the Company’s listing on Toronto Stock Exchange.
Curaleaf is the leading international provider of cannabis consumer products with a mission to enhance lives by… pic.twitter.com/lKzN0StRB0
— Canada’s Markets (@tsx_tsxv) December 14, 2023
The decision to move to the Toronto Stock Exchange is part of a broader trend in the cannabis industry, with TerrAscend doing the same earlier in the year. Both companies seek to improve their access to institutional investors globally and increase long-term stock liquidity.
Alongside this listing, Curaleaf carried out a significant internal reorganization of its US operations, as indicated in their press release. This internal reorganization of Curaleaf aims in particular to make the company more attractive to investors, comply with regulations, improve stock trading and adapt to the challenges and uncertainties of the cannabis industry.
In details :
- Access to a broader investor base: Listing on the Toronto Stock Exchange allows Curaleaf to attract a greater number of investors, including institutional investors. This broader investor base can improve the financial support and liquidity of the company.
- Comply with regulatory requirements: Internal reorganization involves changes in the structure of shares and voting rights of the company. These adjustments are likely made to comply with regulatory requirements, particularly in the context of the evolution and complexity of U.S. cannabis regulations.
- Increase the liquidity of shares: By taking these strategic steps, Curaleaf intends to improve the liquidity of its shares in the long term. This can make it easier for investors to buy and sell shares and potentially increase the overall value of the company.
- Resolving regulatory uncertainties: The creation of a new category of exchangeable shares without voting rights gives shareholders the possibility of converting their shares. This flexibility is designed to help investors navigate the uncertainties surrounding cannabis regulations in the United States.
- Improving corporate governance: The shareholders’ agreement and the protection agreement emphasize governance. These agreements define rights and obligations, providing a clear framework for decision-making and ownership, thereby contributing to a stable and well-governed business structure.
